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A B S T R A C T
A clinical trial was undertaken to evaluate the efficacy of hypertonic solution (5% NaCl) in patients who have bullous
keratopathy (BK). The aim of the study was to define the stage of the disease and the thickness of cornea in micrometers,
which would be the threshold for therapeutic approach. This was a prospective study on 70 eyes of 55 patients. Patients
were divided in two groups at the beginning of the study.The first group (n=33 eyes) included patients with initial stage
of BK: only stromal component of corneal oedema was present. The second group (n=37 eyes) included patients with ad-
vanced stage of BK: the epithelial component of the disease with bullae on the corneal surface had already developed. Vi-
sual acuity, central and peripheral thickness of cornea and morphology of the disease was recorded before therapy, 7 days
and 4 weeks after administration of hypertonic solution. Our results shown that the efficacy of hypertonic solution corre-
lates with the severity of clinical picture in patients with BK. When 5% NaCl hypertonic solution was applied in the early
stage of the disease, when only stromal component of corneal oedema was presented, visual acuity and pachymetry read-
ings were significantly improved. The threshold pachymerty measurement of corneal thickness justifying the application
of hypertonic solution was 613–694 m (in the central corneal area), and 633–728 m (at corneal periphery). It seems rea-
sonable to apply hypertonic solution to the patients who have BK and whose pachymetric values are below mentioned
range. In terminal stages of BK, when superficial bullae (epithelial component) had already developed, treatment with
NaCl was not effective and patients had to be submitted to penetrating keratoplasty.
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Introduction
Opacification of the cornea which occurs in bullous
keratopathy (BK) is often untreatable by conservative
treatment and can only be treated by corneal trans-
plantation1,2. Transparency of the cornea mostly depends
on the endothelial cells function, namely on their num-
ber per mm2 and regularity of their shape and size. If the
majority of endothelial cell layer is impaired due to in-
flammation, trauma, degenerative diseases, toxin or sur-
gical procedure, residual cells are not able to prevent the
entrance of aqueous humor in corneal stromal layer3,4.
As a result, a hyper-hydration of the cornea with conse-
quent stromal edema and epithelial bullae develops. The
loss of endothelial cells can also be genetically deter-
mined as in case of Fuch's endothelial dystrophy5–7. Loss
of visual acuity due to decreased corneal transparency is
one of the symptoms of BK. It is typical for patients with
BK to have lower visual acuity in the morning than in
the evening, because the corneal hydration is increased
during the night when eyelids are closed.
It is easy to assess increased corneal thickness, stro-
mal edema and epithelial bullae by slit-lamp examina-
tion. The endothelial cell layer can be examined by spec-
ular microscope.
There are not many options for treatment of BK.
Hyperosmolar solutions8,9 were reported as potentially
beneficial in symptomatic treatment. The most com-
monly used topical treatments are hypertonic solutions
of NaCl, and the most frequent of them are: Adsorbonac,
SalineX, Ak-NaCl, Hyperton-5 and Muro-128. Recom-
mended dose is 1–2 drops 4–6 times per day but the opti-
mal dose is not yet established, especially with children.
Other therapeutic approaches that can be of benefit
for patients with BK are antiglaucoma drops, application
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of honey10 and therapeutic lens11, transplantation of the
amniotic membrane12,13 and finally corneal transplan-
tation1,2.
The aim of the study was to evaluate the efficacy of
topical 5% NaCl in eyes with different stages of BK. We
also aimed to determine the thickness of cornea which
will be a threshold value for beneficial effect of men-
tioned treatment.
Patients and Methods
We performed a prospective study on 55 ambulatory
patients (70 eyes) suffering from BK. The patients were
divided in two groups. The first group included eyes with
only stromal component of corneal oedema, without epi-
thelial bullae. All patients underwent standard ophthal-
mological evaluation: check of visual acuity by Snellen's
chart, slit-lamp examination, aplanation tonometry, ex-
amination of fundus, and ultrasound examination (B-
scan). Pachymetry of central and peripheral cornea was
performed with ultrasound pachymeter (Alcon, USA).
Patients in the second group had epithelial compo-
nent of corneal oedema and significant bullae on their
corneal surface. All patients underwent same ophthalmic
evaluation as those in the first group, only difference was
a decreased visualization of fundus due to advanced
stage of disease and decreased transparency of optical
media. Both groups were followed up for 4 weeks and
were compared according to following parameters: visual
acuity, central and peripheral corneal thickness, and
morphological changes on day 7 and 4 weeks after the ap-
plication of hypertonic NaCl. The obtained results were
compared with the condition before treatment. Central
and peripheral pachymetry were defined as mean value
of four consecutive measurements: a.) for central pachy-
metry in central 5 mm2 of cornea and b.) for peripheral
pachymetry in four corneal quadrants (12, 3, 6 and 9
clock hours) at 1 millimeter distance from limbus.
Study drug was 5% solution of NaCl. It was prepared
in aseptic conditions in our hospital pharmacy, only for
the purpose of this study. Hypertonic NaCl was adminis-
trated to both groups of patients: 2 drops were given 4
times a day in conjunctival sac.
The obtained results were statistically evaluated by
ANOVA (analysis of variance) regarding to time as a fac-
tor inside of each group, followed by paired student t-test.
Results
In the first group of patients (24 patients with initial
stage of the disease, 14 women and 10 men, n=33 eyes,
age between 65 and 83 years, mean value of intraocular
pressure 15,5±3 mm Hg) a statistically significant im-
provement (p<0.05) of visual acuity (V.A.=0.39±0.063)
occurred one week after topical NaCl in comparison to the
values before the treatment (V.A.=0.25±0.063, Figure 1).
The example of clinical improvement of one patient is rep-
resented by Figure 2, Figure 3, and Figure 4. No further
improvement was recorded during following three weeks
of NaCl application (V.A.=0.4±0.06, Figure 1). Central
pachymetry values significantly decreased after the first
week of hypertonic solution application (582±22 µm) in
comparison with the baseline value (613±33 µm, p<0.05),


























Fig. 1. Changes in visual acuity in patients with bullous
keratopathy treated with 5% NaCl hypertonic solution during 4
weeks. A significant improvement of visual acuity (*p<0.05 in
comparison with the value before treatment) was recorded in pa-
tients with initial stage of the disease (grey bars). No significant
change in visual acuity was recorded in patients with advanced
stage of bullous keratopathy (black bars).
Fig. 3. Patient with bullous keratopathy 7 days after topical
treatment with 5% NaCl hypertonic solution.
Fig. 2. Patient with bullous keratopathy before topical treatment
with 5% NaCl hypertonic solution.
and remained the same during the next three weeks of
treatment (Figure 5). Normal range of central corneal
thickness is 548±21.2 µm14. Namely, after the first week
of NaCl application, no further decrease of central corneal
thickness was recorded (578±27 µm at 4 weeks). Periph-
eral pachymetry values also decreased 1 (602±26 µm,
p<0.05) and 4 (579 ±26 µm, p<0.05) weeks after the ap-
plication of hypertonic solution in comparison with the
baseline value (633±54 µm, Figure 6). Four weeks after
application of hypertonic solution, no statistically signifi-
cant change in corneal thickness was presented, in com-
parison with the values after 1 week.
In the second group of patients with the advanced
stage of BK (31 patients, 14 women and 17 men, n=37
eyes, age between 63 and 86 years), there was no statisti-
cally significant change of visual acuity either one (V.A.=
0.057±0.035, p>0.05) or four weeks (V.A.=0.05±0.032,
p>0.05) after local application of 5% NaCl in comparison
with the baseline value (V.A.=0.047±0.034, Figure 1).
Peripheral pachymetry was also unchanged after one
(716±83 µm, p>0.05) and four weeks (714±95 µm, p>
0.05) of treatment in comparison with the baseline value
(728±76 µm, Figure 6).
However, there was a statistically significant decrease
of central pachymetric values 1 week (675±93 µm, p<
0.05) after local application of 5% NaCl in comparison
with the baseline value (694±84 µm). Four weeks after
application of 5% NaCl central pachymetry values were
unchanged (681±99 µm, p>0.05) in comparison with
both, baseline and values after 1 week (Figure 5).
Discussion
Takahashi and Leibowitz were the first who reported
on visual improvement after the administration of hy-
pertonic solution on patients with bullous keratopathy8.
Assumed mechanism of 5% NaCl action was the evacua-
tion of corneal edema due to hypertonic properties of this
solution. However, it is still unclear at which stage of the
disease patients with BKmay benefit from hypertonic so-
lution, and does the efficacy of 5% NaCl depend on the
baseline corneal thickness. It would be of clinical impor-
tance to define maximal corneal pachymetric values at
which administration of hypertonic solution can have
therapeutic effect. The respective value could be the dis-
tinguishing threshold between indication for conserva-
tive treatment (hypertonic solution) or surgical approach
- corneal transplantation.
It is well known from the literature that the applica-
tion of the therapeutic lens without concomitant therapy
(hypertonic solution) can not improve corneal edema11.
Surgical procedures, e.g. transplantation of the amniotic
membrane (TAM), have shown beneficial effect regard-
ing decrease of pain and discomfort in patients with
bullous keratopathy. However, there is no precise data
about influence of TAM on visual acuity and pachymetric
values, and there are no studies comparing efficacy of
TAM versus hypertonic solution12,13.
It is important to emphasize that the treatment with
hypertonic solution is only symptomatic and requires con-
tinuity since it does not influence the etiology of disease.
I. Knezovi} et al.: Hyperosmolar Treatment of Bullous Keratopathy, Coll. Antropol. 30 (2006) 2: 405–408
407
Fig. 4. Patient with bullous keratopathy four weeks after topical



































Fig. 5. Changes in central corneal pachymetry in patients with
bullous keratopathy during four weeks of treatment with 5% NaCl
hypertonic solution. A significant decrease in pachymetry value
(*p<0.05 in comparison with the value before treatment) was re-
corded in patients with initial stage of bullous keratopathy (grey
































Fig. 6. Changes in peripheral corneal pachymetry in patients with
bullous keratopathy during four weeks of treatment with 5% NaCl
hypertonic solution. A significant decrease in pachymetry value
(*p<0.05 in comparison with the value before treatment) was re-
corded in patients with initial stage of bullous keratopathy (grey
bars). No significant change in peripheral corneal pachymetry
was recorded in patients with advanced stage of bullous kerato-
pathy (black bars).
Therefore, accurate estimation (by pachymetry) which pa-
tient can benefit fromNaCl treatment could be beneficial.
In our study we have shown that NaCl may indeed be
beneficial for patients with BK, but only in a selected
group of such patients. Namely, in the early stage of BK
the administration of hypertonic solution led to signifi-
cant improvement of visual acuity. Rationale for this im-
provement lays in significant dehydration of the corneal
tissue, since both central and peripheral pachymetric
values were significantly lower after the treatment. In
the terminal stage of the disease, with developed stromal
and epithelial component of corneal edema, local admin-
istration of hypertonic solution did not show any signifi-
cant change in the progress of the disease. There was no
statistical difference in visual acuity or peripheral pa-
chymetry both, 1 and 4 weeks after local administration
of 5% NaCl. However, there was a slight and transitory
decrease in central pachymetric values 7 days after treat-
ment in comarision with the baseline value that re-
mained stable up to 4 weeks.
Our results implicate that it is possible to predict the
efficacy of NaCl treatment according to values of central
and peripheral corneal pachymetry. It is reasonable to
conclude that hypertonic solution of 5% NaCl may be
beneficial for the patients with BK having central pachy-
metry values of 613–694 µm and peripheral pachymetry
values between 633–728 µm.
These respective values are the range of threshold of
corneal thickness, and in the advanced stage of BK, when
both stromal and epithelial components of the disease have
already developed, the pachymetric values will be above
mentioned range and, therefore, hypertonic solution has no
therapeutic effect. For these patients, corneal transplanta-
tion remains the only valuable treatment to improve their
visual acuity and resolve painful symptoms of BK.
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DJELOVANJE HIPERTONI^NE OTOPINE 5% NaCl NA EDEM RO@NICE KOD BOLESNIKA
S BULOZNOM KERATOPATIJOM
S A @ E T A K
U bolesnika s buloznom keratopatijom u~injena je klini~ka studija radi evaluacije djelotvornosti hipertoni~ne oto-
pine 5% NaCl. Cilj studije bio je definirati stadij bolesti i debljinu ro`nice (mm) koja bi trebala biti „prag« za odluku o
primjeni konzervativnog ili operativnog terapijskog pristupa. Ova prospektivna studija obuhvatila je 70 o~iju u 55 bole-
snika s razli~itim stadijem bulozne keratopatije. Bolesnici s buloznom keratopatijom podijeljeni su u dvije skupine. U
prvoj skupini bili su bolesnici koji su imali razvijenu samo stromalnu komponentu ro`ni~nog edema (inicijalni stadij)
(n=33, 24 bolesnika), dok je druga skupina obuhvatila bolesnike (n=37, 31 bolesnik) s razvijenom epitelnom kompo-
nentom ro`ni~nog edema i s vidljivim bulama po povr{ini ro`nice (uznapredovali stadij). Mjerenja vidne o{trine, deblji-
ne ro`nice centralno i periferno (pahimetrija) te evaluacija morfolo{kih promjena, ra|eni su prije po~etka terapije, 7
dana nakon po~etka terapije hipertoni~nom otopinom 5% NaCl, te tijekom slijede}a 3 tjedna. Rezultati istra`ivanja
pokazali su da je stupanj u~inkovitosti djelovanja hipertoni~ne otopine 5% NaCl na ro`ni~ni edem u korelaciji sa sta-
dijem bolesti. Ukoliko se hipertoni~na otopina 5% NaCl primijeni u inicijalnom stadiju bulozne keratopatije, gore nave-
dena terapija ima zadovoljavaju}i u~inak. Vidljivo je da prag koji opravdava u~inkovitu primjenu hipertoni~ne otopine
5% NaCl, pri centralnoj pahimetriji ima raspon od 613 µm do 694 µm, a perifernoj od 633 µm do 728 µm. Zaklju~ak je da
doti~ni parametri predstavljaju raspon praga u pahimetrijskim vrijednostima ispod kojih ima smisla bolesnika podvr-
gnuti terapiji hipertoni~nom otopinom 5% NaCl. Ako se radi o uznapredovalom stadiju bulozne keratopatije, za potpu-
no izlje~enje bolesnika potrebno je napraviti transplantaciju ro`nice.
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